Bronstein, Gewirtz & Grossman, LLC Is Investigating Cellebrite DI Ltd. (CLBT) And Encourages Shareholders to Connect
Alpha Vantage · The National Law Review · · AI-summarised by FinFlash
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cellebrite DI Ltd. (NASDAQ:CLBT). This investigation follows Cellebrite's August 13, 2026, report of second-quarter financial results which included missed Annual Recurring Revenue guidance, a lowered full-year ARR outlook, and the abrupt replacement of CEO Tom Hogan, leading to a significant drop in its stock price. The firm is encouraging affected shareholders to contact them to assist with the investigation.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.